fluocinolone acetonide has been researched along with Pulmonary Disease, Chronic Obstructive in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lavorini, F; Pedersen, S; Usmani, OS | 1 |
| Melani, AS | 1 |
| Biraghi, M; Di Franco, A; Fano, M; Paggiaro, PL; Vagaggini, B; Zingoni, M | 1 |
2 review(s) available for fluocinolone acetonide and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Dilemmas, Confusion, and Misconceptions Related to Small Airways Directed Therapy.
Topics: Administration, Inhalation; Asthma; Beclomethasone; Bronchioles; Bronchodilator Agents; Disease Management; Drug Combinations; Dry Powder Inhalers; Equipment Design; Fluocinolone Acetonide; Formoterol Fumarate; Glucocorticoids; Humans; Inhalation Spacers; Metered Dose Inhalers; Nebulizers and Vaporizers; Particle Size; Pregnenediones; Pressure; Pulmonary Disease, Chronic Obstructive | 2017 |
Nebulized corticosteroids in asthma and COPD. An Italian appraisal.
Topics: Administration, Inhalation; Androstadienes; Asthma; Beclomethasone; Dose-Response Relationship, Drug; Equipment Design; Fluocinolone Acetonide; Fluticasone; Glucocorticoids; Humans; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive | 2012 |
1 trial(s) available for fluocinolone acetonide and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Efficacy of nebulized flunisolide combined with salbutamol and ipratropium bromide in stable patients with moderate-to-severe chronic obstructive pulmonary disease.
Topics: Aged; Albuterol; Anti-Asthmatic Agents; Bronchodilator Agents; Double-Blind Method; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Forced Expiratory Volume; Humans; Ipratropium; Male; Middle Aged; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive; Surveys and Questionnaires; Treatment Outcome | 2006 |
1 other study(ies) available for fluocinolone acetonide and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Use of ozone-depleting substances; removal of essential-use designation (flunisolide, etc.). Final rule.
Topics: Air Pollutants; Air Pollution; Albuterol; Anti-Asthmatic Agents; Asthma; Atmosphere; Bronchodilator Agents; Chemistry, Pharmaceutical; Chlorofluorocarbons; Drug Costs; Drug Therapy, Combination; Fluocinolone Acetonide; Humans; Ipratropium; Metaproterenol; Nebulizers and Vaporizers; Ozone; Pulmonary Disease, Chronic Obstructive; Triamcinolone; United States | 2010 |